Matches in SemOpenAlex for { <https://semopenalex.org/work/W2797389618> ?p ?o ?g. }
- W2797389618 endingPage "1237" @default.
- W2797389618 startingPage "1229" @default.
- W2797389618 abstract "Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study Timm Greulich,1 Konstantinos Kostikas,2 Mina Gaga,3 Maryam Aalamian-Mattheis,2 Nadine S Lossi,4 Francesco Patalano,2 Xavier Nunez,5 Veronica A Pagano,5 Robert Fogel,6 Claus F Vogelmeier,1,* Andreas Clemens2,7,* 1University Medical Center Giessen and Marburg, German Center for Lung Research (DZL), Marburg, Germany; 2Novartis Pharma AG, Basel, Switzerland; 37th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece; 4Novartis Pharma GmbH, Nürnberg, Germany; 5TFS Develop, Barcelona, Spain; 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 7Heart Center Freiburg University, Cardiology and Angiology I, Faculty of Medicine, Freiburg, Germany *These authors contributed equally to this work Purpose: COPD is a progressive disease characterized by exacerbations and a decline in health status and lung function. Clinically important deterioration (CID) is a composite endpoint used to evaluate treatment efficacy. This analysis evaluated the impact of a direct switch to once-daily indacaterol/glycopyrronium 110/50 µg (IND/GLY) from previous monotherapy with a long-acting β2-agonist (LABA) or long-acting muscarinic antagonist (LAMA) or with an LABA and an inhaled corticosteroid (LABA + ICS) on reducing CID. Methods: CRYSTAL was a 12-week, prospective, multicenter, randomized, open-label study conducted in clinical practice settings. Three definitions of CID (D1–D3) were used, including: 1) ≥100 mL decrease in trough forced expiratory volume in 1 second (FEV1), 2) ≥1 point decrease in transition dyspnea index (TDI) and/or ≥0.4 points increase in clinical COPD questionnaire score (CCQ), or 3) an acute moderate/severe exacerbation (AECOPD). In D1 and D2, either TDI or CCQ was evaluated along with FEV1 and AECOPD, whereas in D3, all 4 parameters were included. ClinicalTrials.gov number: NCT01985334. Results: Of the 2,159 patients analyzed, 1,622 switched to IND/GLY and 537 continued their baseline treatments. The percentage of patients with a CID was significantly lower after a direct switch to IND/GLY versus LABA or LAMA using all 3 CID definitions (D1: odds ratio [OR] 0.41 [95% CI: 0.30–0.55]; D2: OR 0.41 [95% CI: 0.31–0.55]; D3: OR 0.39 [95% CI: 0.29–0.52]). Compared with LABA + ICS, IND/GLY also reduced the risk of CID (D1: OR 0.76 [95% CI: 0.56–1.02]; D2: OR 0.75 [95% CI: 0.56–1.00]; D3: OR 0.67 [95% CI: 0.51–0.89]). Conclusion: In this analysis, IND/GLY reduced the risk of a CID in moderate COPD patients after direct switch from LABA + ICS or LABA or LAMA in real-life clinical practice. Keywords: clinically important deterioration/CID, direct-switch, pragmatic, open-label, clinical COPD questionnaire/CCQ, transition dyspnea index/TDI" @default.
- W2797389618 created "2018-04-24" @default.
- W2797389618 creator A5014491389 @default.
- W2797389618 creator A5019355371 @default.
- W2797389618 creator A5036976413 @default.
- W2797389618 creator A5038363316 @default.
- W2797389618 creator A5040823984 @default.
- W2797389618 creator A5059684830 @default.
- W2797389618 creator A5064085023 @default.
- W2797389618 creator A5072678137 @default.
- W2797389618 creator A5083899819 @default.
- W2797389618 creator A5085245138 @default.
- W2797389618 creator A5087895313 @default.
- W2797389618 date "2018-04-01" @default.
- W2797389618 modified "2023-09-23" @default.
- W2797389618 title "Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study" @default.
- W2797389618 cites W1637753636 @default.
- W2797389618 cites W1980903642 @default.
- W2797389618 cites W2018323223 @default.
- W2797389618 cites W2056040906 @default.
- W2797389618 cites W2116505643 @default.
- W2797389618 cites W2123850585 @default.
- W2797389618 cites W2142449488 @default.
- W2797389618 cites W2171676943 @default.
- W2797389618 cites W2365138737 @default.
- W2797389618 cites W2406141956 @default.
- W2797389618 cites W2467721645 @default.
- W2797389618 cites W2544647701 @default.
- W2797389618 cites W2576614024 @default.
- W2797389618 cites W2610600399 @default.
- W2797389618 cites W2617148967 @default.
- W2797389618 cites W2738246554 @default.
- W2797389618 cites W2344302006 @default.
- W2797389618 doi "https://doi.org/10.2147/copd.s159732" @default.
- W2797389618 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5909796" @default.
- W2797389618 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29713156" @default.
- W2797389618 hasPublicationYear "2018" @default.
- W2797389618 type Work @default.
- W2797389618 sameAs 2797389618 @default.
- W2797389618 citedByCount "16" @default.
- W2797389618 countsByYear W27973896182019 @default.
- W2797389618 countsByYear W27973896182020 @default.
- W2797389618 countsByYear W27973896182021 @default.
- W2797389618 countsByYear W27973896182022 @default.
- W2797389618 countsByYear W27973896182023 @default.
- W2797389618 crossrefType "journal-article" @default.
- W2797389618 hasAuthorship W2797389618A5014491389 @default.
- W2797389618 hasAuthorship W2797389618A5019355371 @default.
- W2797389618 hasAuthorship W2797389618A5036976413 @default.
- W2797389618 hasAuthorship W2797389618A5038363316 @default.
- W2797389618 hasAuthorship W2797389618A5040823984 @default.
- W2797389618 hasAuthorship W2797389618A5059684830 @default.
- W2797389618 hasAuthorship W2797389618A5064085023 @default.
- W2797389618 hasAuthorship W2797389618A5072678137 @default.
- W2797389618 hasAuthorship W2797389618A5083899819 @default.
- W2797389618 hasAuthorship W2797389618A5085245138 @default.
- W2797389618 hasAuthorship W2797389618A5087895313 @default.
- W2797389618 hasBestOaLocation W27973896181 @default.
- W2797389618 hasConcept C126322002 @default.
- W2797389618 hasConcept C170493617 @default.
- W2797389618 hasConcept C2776042228 @default.
- W2797389618 hasConcept C2776780178 @default.
- W2797389618 hasConcept C2778884479 @default.
- W2797389618 hasConcept C2779591629 @default.
- W2797389618 hasConcept C2780911369 @default.
- W2797389618 hasConcept C2781018748 @default.
- W2797389618 hasConcept C3017940444 @default.
- W2797389618 hasConcept C71924100 @default.
- W2797389618 hasConceptScore W2797389618C126322002 @default.
- W2797389618 hasConceptScore W2797389618C170493617 @default.
- W2797389618 hasConceptScore W2797389618C2776042228 @default.
- W2797389618 hasConceptScore W2797389618C2776780178 @default.
- W2797389618 hasConceptScore W2797389618C2778884479 @default.
- W2797389618 hasConceptScore W2797389618C2779591629 @default.
- W2797389618 hasConceptScore W2797389618C2780911369 @default.
- W2797389618 hasConceptScore W2797389618C2781018748 @default.
- W2797389618 hasConceptScore W2797389618C3017940444 @default.
- W2797389618 hasConceptScore W2797389618C71924100 @default.
- W2797389618 hasLocation W27973896181 @default.
- W2797389618 hasLocation W27973896182 @default.
- W2797389618 hasLocation W27973896183 @default.
- W2797389618 hasLocation W27973896184 @default.
- W2797389618 hasOpenAccess W2797389618 @default.
- W2797389618 hasPrimaryLocation W27973896181 @default.
- W2797389618 hasRelatedWork W2006842712 @default.
- W2797389618 hasRelatedWork W2024892593 @default.
- W2797389618 hasRelatedWork W2114580482 @default.
- W2797389618 hasRelatedWork W2432028869 @default.
- W2797389618 hasRelatedWork W2565055415 @default.
- W2797389618 hasRelatedWork W2810049546 @default.
- W2797389618 hasRelatedWork W4232328075 @default.
- W2797389618 hasRelatedWork W4248150072 @default.
- W2797389618 hasRelatedWork W4292183227 @default.
- W2797389618 hasRelatedWork W4311105762 @default.
- W2797389618 hasVolume "Volume 13" @default.
- W2797389618 isParatext "false" @default.
- W2797389618 isRetracted "false" @default.
- W2797389618 magId "2797389618" @default.